מחיר חזוי לרווח: EDAP TMS (EDAP)

EDAP TMS S.A. leads in robotic ultrasound therapy for prostate cancer, as confirmed by the company's forward P/E ratio on the GURU.Markets daily price chart, where the latest value is recorded as 0.00. Slow insurance approvals in the US and sales force expenses are weighing on profits, although the company retains staff through private health insurance and the uniqueness of its niche.
פילוחי מדדים ואנליטיקה של חברת EDAP Medical (EDAP)

Steady demand for EDAP TMS S.A. (EDAP) urological equipment minimizes earnings volatility, allowing for a fair value assessment of shares based on expected income through the company's forward P/E ratio history. This indicator correlates the current market price with projected net profit, helping investors distinguish speculative growth from fundamental business strengthening amid the sector's high macroeconomic resilience.